Literature DB >> 2313092

IL-1 beta is secreted by activated murine macrophages as biologically inactive precursor.

H U Beuscher1, C Günther, M Röllinghoff.   

Abstract

IL-1 alpha and IL-beta are distinct cytokines, produced by activated macrophages. The temporal sequence in the processing and secretion as well as the mechanism(s) by which IL-1 is secreted from the cells remain undefined. Here we have studied the production of IL-1 from murine macrophages after stimulation with LPS or Listeria monocytogenes by two distinct methods: i) immunoprecipitation of radio-labeled IL-1 peptides from culture supernatants, and ii) determination of IL-1 activity by neutralization with monospecific antisera to either form of IL-1. We confirmed that precursor and mature forms of both IL-1 alpha and IL-1 beta can be detected in the culture supernatants after stimulation of the macrophages with 10 to 20 micrograms LPS/ml but, in addition, we report the novel finding that IL-1 beta is exclusively secreted in its unprocessed precursor form after stimulation of the cells with either 0.5 to 1 microgram LPS/ml or with L. monocytogenes. Exposure of the cells to increasing amounts of LPS led to the appearance of a 20-kDa IL-1 beta peptide in the culture supernatants concomitant with the release of a processing activity for the IL-1 beta precursor. These data therefore suggest that, in a first step, IL-1 beta is secreted as an unprocessed precursor protein that in a second, postsecretory step is cleaved by a LPS-inducible protease, thus generating the 20-kDa IL-1 beta peptide. The latter represents the biologically active IL-1 beta inasmuch as the generation of IL-1 beta activity in the culture supernatants strictly correlated with the appearance of the 20-kDa IL-1 beta peptide.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2313092

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  34 in total

Review 1.  Current status and challenges of cytokine pharmacology.

Authors:  Z Zídek; P Anzenbacher; E Kmonícková
Journal:  Br J Pharmacol       Date:  2009-04-03       Impact factor: 8.739

2.  Increased cyclic AMP levels enhance IL-1 alpha and IL-1 beta mRNA expression and protein production in human myelomonocytic cell lines and monocytes.

Authors:  S S Sung; J A Walters
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

Review 3.  Survival of encapsulated islets: More than a membrane story.

Authors:  Uriel Barkai; Avi Rotem; Paul de Vos
Journal:  World J Transplant       Date:  2016-03-24

4.  Platelets Mediate Host Defense against Staphylococcus aureus through Direct Bactericidal Activity and by Enhancing Macrophage Activities.

Authors:  Ramadan A Ali; Leah M Wuescher; Keith R Dona; Randall G Worth
Journal:  J Immunol       Date:  2016-11-28       Impact factor: 5.422

5.  Prenatal opiate exposure attenuates LPS-induced fever in adult rats: role of interleukin-1beta.

Authors:  Kathryn L Hamilton; La 'Tonyia M Franklin; Sabita Roy; Lisa M Schrott
Journal:  Brain Res       Date:  2006-12-28       Impact factor: 3.252

6.  IL-12-induced IFN-gamma is dependent on caspase-1 processing of the IL-18 precursor.

Authors:  G Fantuzzi; D A Reed; C A Dinarello
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

7.  Stimulation and release of interleukin-1 from peritoneal macrophages of the mouse.

Authors:  A K Bahl; J C Foreman
Journal:  Agents Actions       Date:  1994-10

8.  Interleukin 1 is processed and released during apoptosis.

Authors:  K A Hogquist; M A Nett; E R Unanue; D D Chaplin
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

9.  Molecular cloning and characterization of ovine IL-1 alpha and IL-1 beta.

Authors:  A E Andrews; G J Barcham; M R Brandon; A D Nash
Journal:  Immunology       Date:  1991-11       Impact factor: 7.397

10.  IL-1R signaling within the central nervous system regulates CXCL12 expression at the blood-brain barrier and disease severity during experimental autoimmune encephalomyelitis.

Authors:  Erin E McCandless; Matthew Budde; Jason R Lees; Denise Dorsey; Eric Lyng; Robyn S Klein
Journal:  J Immunol       Date:  2009-06-17       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.